title: Pharmacology of benzydamine.
abstract: Benzydamine is a topical anti-inflammatory drug which is widely available and used topically for the treatment of the mouth. It is also used as a gel for application to inflamed joints. It has physicochemical properties and pharmacological activities which differ markedly from those of the aspirin-line non-steroidal anti-inflammatory drugs. Benzydamine is a weak base unlike the aspirin-like drugs which are acids or metabolized to acids. A major contrast with the aspirin-like drugs is that benzydamine is a weak inhibitor of the synthesis of prostaglandins but it has several properties which may contribute to its anti-inflammatory activity. These properties include inhibition of the synthesis of the inflammatory cytokine, tumour necrosis factor-alpha (EC(50), 25 micromol/L). Inhibition of the oxidative burst of neutrophils occurs under some conditions at concentrations of 30 to 100 micromol/L, concentrations which may be produced within oral tissues after local application. A further activity of benzydamine is a general activity known as membrane stabilization which is demonstrated by several actions including inhibition of granule release from neutrophils at concentrations ranging from 3 to 30 micromol/L and stabilization of lysosomes. Lack of knowledge of the tissue concentrations of benzydamine limit the correlation between pharmacological activities in vitro and in vivo. The concentration of benzydamine in the mouthwash is 4 mmol/L but the concentrations in oral tissues have not been studied adequately. Limited data in the rat indicates that concentrations of benzydamine in oral tissues are approximately 100 micromol/L.
authors: School of Physiology and Pharmacology, University of NSW, Sydney, Australia.
authors: P A
authors: PA
authors: Quane
authors: G G
authors: GG
authors: Graham
authors: J B
authors: JB
authors: Ziegler
references: Arzneimittelforschung. 1987 May;37(5A):618-21
references: 3619982
references: Arzneimittelforschung. 1974 Oct;24(10):1686-8
references: 4479782
references: J Ocul Pharmacol. 1989 Spring;5(1):71-80
references: 2715678
references: Arch Int Pharmacodyn Ther. 1966 Sep;163(1):61-9
references: 5970856
references: Therapie. 1970 Jan-Feb;25(1):43-60
references: 5436803
references: J Pharm Pharmacol. 1967 Dec;19:Suppl:31S-41S
references: 4383854
references: Cytokine. 1996 Sep;8(9):710-6
references: 8932982
references: Biochem Pharmacol. 1969 Jul;18(7):1707-10
references: 5806111
references: Agents Actions. 1985 Jul;16(5):346-52
references: 2996321
references: Arthritis Rheum. 1987 Aug;30(8):908-13
references: 3632731
references: Prostaglandins. 1973 Sep;4(3):325-41
references: 4783568
references: Aust Dent J. 1978 Apr;23(2):164-6
references: 361026
references: Med Pharmacol Exp Int J Exp Med. 1966;15(2):102-6
references: 6012722
references: Arzneimittelforschung. 1996 Mar;46(3):320-3
references: 8901158
references: Int J Tissue React. 1985;7(3):195-204
references: 4044147
references: Arzneimittelforschung. 1971 Oct;21(10):1530-3
references: 4945249
references: Biochem Pharmacol. 1987 Apr 1;36(7):1125-32
references: 3032204
references: Br J Anaesth. 1996 Nov;77(5):645-52
references: 8957983
references: Arzneimittelforschung. 1985;35(3):634-5
references: 4039589
references: Int J Tissue React. 1987;9(2):93-7
references: 3610518
references: Biochem Pharmacol. 1977 Jan 1;26(1):11-8
references: 576205
references: Arzneimittelforschung. 1987 May;37(5A):601-5
references: 3040020
references: Arzneimittelforschung. 1966 Oct;16(10):1354-7
references: 6014929
references: J Oral Med. 1985 Apr-Jun;40(2):67-71
references: 3858465
references: Prostaglandins. 1976 Sep;12(3):323-35
references: 968048
references: Chem Pharm Bull (Tokyo). 1979 Dec;27(12):2890-903
references: 540330
references: Biochem Pharmacol. 1996 Jul 26;52(2):341-9
references: 8694859
references: Br J Anaesth. 1996 Jun;76(6):806-10
references: 8679354
references: Biochem Pharmacol. 1972 Jul 15;21(14):1991-3
references: 4649346
references: Oral Surg Oral Med Oral Pathol. 1986 Aug;62(2):145-8
references: 3528978
references: Br J Anaesth. 1986 Jun;58(6):639-45
references: 3011043
references: Arzneimittelforschung. 1987 May;37(5A):626-8
references: 3619983
references: Biochem Pharmacol. 1976 Feb 1;25(3):299-303
references: 178318
references: Int J Tissue React. 1985;7(3):205-13
references: 3899969
references: Biochem Pharmacol. 1979 Sep 15;28(18):2723-8
references: 115474
references: J Int Med Res. 1977;5(6):450-8
references: 338395
references: Biochem Pharmacol. 1976 Jul 1;25(13):1473-80
references: 8043
references: Biochem Pharmacol. 1987 Aug 1;36(15):2511-7
references: 3038127
references: J Pharm Pharmacol. 1969 Mar;21(3):160-8
references: 4388211
references: Oral Surg Oral Med Oral Pathol. 1987 Feb;63(2):189-91
references: 3469601
references: Biochem Soc Trans. 1979 Aug;7(4):655-7
references: 113266
references: FEBS Lett. 1977 Oct 1;82(1):107-10
references: 913565
references: Anaesthesia. 1989 Dec;44(12):990-1
references: 2619026
references: Biochem Biophys Res Commun. 1996 Apr 16;221(2):266-70
references: 8619844
references: J Chemother. 1992 Dec;4(6):347-52
references: 1287137
references: Curr Med Res Opin. 1982;8(3):188-90
references: 7128190
references: Eur J Pharmacol. 1968 May;3(2):157-62
references: 5666012
references: Int J Tissue React. 1985;7(3):187-93
references: 4044146
references: Toxicol Appl Pharmacol. 1967 Jan;10(1):148-59
references: 6031923
references: Biopharm Drug Dispos. 1991 Oct;12(7):481-92
references: 1932611
references: Pract Odontol. 1990 Jul;11(7):29-31, 34
references: 2132273